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Abstract
Background: Salmonella Typhimurium (S. Typhimurium) inactivated by a regulated autolysis system was genetically
engineered to express the homo-pentameric B subunit of Shiga toxin 2e (Stx2eB) on its surface. To prepare a strain
able to yield autolyzed Salmonella bearing Stx2eB, the plasmid pJHL184 harboring stx2eB gene was transformed into
the attenuated S. Typhimurium strain, JOL1454. Stx2eB subcloned into the antigen delivery cassette of the plasmid
was expressed as fusion protein with the outer membrane protein
Results: The expression of Stx2eB fused to the signal peptide in JOL1454 was validated by immunoblot analysis.
To determine the immunogenicity of JOL1454, female BALB/c mice were intramuscularly injected with 1 × 108
CFU of the inactivated cells at weeks 0 and 2. Significantly elevated levels of IgG and IgA specific to Stx2eB was
observed at weeks 4 and 6 post-immunization (PI) (P <0.05). Proportion of CD3+CD4+ T lymphocyte subpopulation
was also significantly augmented in in vivo stimulated splenocytes relative to that in the control group. The
increased titers of IgG1 and IgG2a, and of immunomodulatory cytokines indicated that the immunization
elicited Th1 and Th2 immune responses. Further, immunomodulatory cytokine genes (IL-6, IL-17A, IL21 and
JOL1454) efficiently upregulated in naïve porcine peripheral blood mononuclear cells (PBMCs) pulsed with
JOL1454. At week 6 PI, following the challenge with a virulent Stx2e-producing Escherichia coli in the mice,
all immunized mice survived whereas approximately 30% of the mice in the control group died.
Conclusions: JOL1454 provided superior immunogenicity and effective protection against challenge with a
sublethal dose, which demonstrates its potential as a candidate vaccine against edema disease.
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Background
Among Shiga toxin-producing Escherichia coli (STEC)
strains, Stx2e is the second most common subtype of
stx2 found in isolates from environmental sources [1].
Although STEC harboring the stx2e gene has only rarely
been detected in human feces, causing mild diarrhea [2],
stx2e is the most frequently encountered variant of stx
gene in STEC isolated from porcine feces [3], and STEC
harboring the stx2e gene has been reported to contribute
to the virulence of edema disease (ED) in weaned piglets
[4]. Shiga toxin 2e, encoded by the stx2e gene, inhibits
protein biosynthesis by ribosome inactivation, which is
chiefly responsible for the clinical signs and lesions of
ED, including subcutaneous and submucosal edema. In
addition, brain vascular injury caused by endothelial cell
edema can elicit fatal neurological disorders and sudden
deaths [4]. Binding of the non-toxic pentamer B subunits
of Stx2e (Stx2eB) to the cell surface globotetraosylcera-
mide (Gb4Cer) receptor allows the toxic A subunit of
Stx2e (Stx2eA) to enter the cytoplasm, where cytotoxic
effects occur [5]. Prevention of Stx2eB binding to the
relevant receptors located on the intestines and cerebral
endothelial cells thus represents a possible mechanism
to prevent the transmission of this pathogen. Hence,
Stx2eB may represent a practical target for the gener-
ation of neutralizing antibodies that could contribute to
impairing the interaction between Stx2eB and cell
surface receptors on intestines, thereby inhibiting the
subsequent cytotoxic effects on epithelial cells that are
mediated by Shiga toxin [5].
ED causes significant economic losses due to sudden
deaths of infected pigs. The factors affecting the preva-
lence of ED are not clearly understood, despite mortality
rates due to ED as high as 50 to 90% [6], with substantial
variance among countries and farming units, and
depending on the health status of the infected pigs. Elab-
orate efforts have been made in an attempt to reduce
disease burden and economic loss in the swine industry.
In particular, the need for optimal vaccination strategies
against ED has increased, as frequently reported inci-
dences of antimicrobial-resistant STEC in swine farms
worldwide become progressively more burdensome to
public health [7]. In addition, the administration of anti-
biotics appears to come too late to treat diseased pigs,
since even when antibiotics are administered at the on-
set of visible clinical signs, severe neurological symptoms
subsequently develop. Accordingly, several vaccine strat-
egies based on targeting Shiga toxin have arisen. Active
and passive immunization of piglets with an Stx2e
toxoid has been reported to provide protection against
challenge with Stx2e toxin [6]. However, those results
did not imply that the toxoid would protect piglets
against virulent STEC infection. Live attenuated STEC
carrying genetically modified Stx2e has been constructed
that confers somewhat effective protection against a
challenge with a lethal dose [6], although a high degree
of reactogenicity remained. Thus, despite the continuous
effort to improve vaccines against ED, no commercial
vaccine is currently available.
A virulent strain of Salmonella Typhimurium has been
successfully prepared for use in expressing a broad range
of homologous antigens, to induce enhanced immune
responses against them [8]. To minimize the risk of live
attenuated Salmonella reverting to a virulent strain,
autolyzed ghost strains derived from Salmonella enterica,
including S. Enteritis [9], S. Gallinarum [10], and S. Typhi
[11] have been genetically engineered for use as candidate
vaccines or vaccine delivery carriers. Inactivated bacterial
ghosts retaining the entire surface antigenic features of the
original bacteria can efficiently target antigen-presenting
cells and induce strong immunological responses [12].
A particular form of autolyzed bacteria generated via
PhiX174 E gene-mediated lysis, so-called “bacterial
ghosts” (BGs), are non-living gram-negative bacterial cell
envelopes that lack cytoplasmic contents, yet conserve
all the surface components of their parental bacteria
[12, 13]. BGs have induced strong immunological
immune responses against retained surface antigenic
determinants, such as lipopolysaccharide and peptido-
glycan [14]. The capacity of BGs as a presentation
system for heterologous antigens has been evaluated
in previous studies [15, 16]. Foreign target proteins
presented by BGs have been successfully expressed as
outer membrane proteins via fusion with signal
sequences, or been translocated into the periplasmic
space [16]. Salmonella ghost strains have been widely
used as vehicles for antigen delivery due to their
ability to induce adjuvant effects by invading host im-
mune systems [15]. In the present study, an attenu-
ated S. Typhimurium strain harboring a recombinant
plasmid carrying a lysis gene permitting induction of
bacterial autolysis, as well as the stx2eB gene, was
constructed. Lysis of S. Typhimurium was mediated
by the PhiX174 E gene under the control of the face-
to-face promoter system to generate S. Typhimurium
ghost cells [17]. During lysis, Stx2eB protein fused
with the outer membrane protein A signal peptide
(ompA ss) is expressed, which enables Stx2eB to be
exported across membranes of autolyzed cells. The
immunogenicity of S. Typhimurium ghosts expressing
Stx2eB was evaluated in a mouse model, and protect-
ive efficacy was also examined by challenging immu-
nized mice with virulent STEC.
Methods
Bacterial strains and culture conditions
All bacteria strains and plasmids used in this study are
described in Table 1. The S. Typhimurium mutant
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strains, Δasd Δlon ΔcpxR JOL912 and Δasd Escherichia
coli χ6212, were grown in either Luria-Bertani (LB)
broth or LB agar at 37 °C with 50 μg/ml of diaminopi-
melic acid (DAP) (Sigma-Aldrich, St. Louis, MO). The
bacterial strains harboring the ghost plasmid were grown
at 28 °C in nutrient broth (NB) containing 0.2% L-ara-
binose. All bacterial strains were stored at −80 °C in
growth medium containing 20% glycerol.
Construction of Salmonella ghosts bearing Stx2eB
The S. Typhimurium mutant strain Δasd Δlon ΔcpxR,
JOL912, was prepared by allelic exchange methods as
previously described [18]. The ghost plasmid, pJHL184,
carries a pBR origin, a multiple cloning site (MCS), a C-
terminal His-tag, and a ghost cassette [19]. The stx2eB
gene was amplified by polymerase chain reaction (PCR)
from wild-type STEC JOL606 isolated from pig diarrhea,
using the primer pair, S1: 5’-ccgccaattcaagaagatgtt-
tatggcg-3’ and S2: 5’-ccgcaagcttgtcattattaaactgcac-3’. The
thermal cycle parameters of the PCR reaction consisted
of an initial denaturation at 94 °C for 5 mins, followed
by 30 cycles of 95 °C for 15 s, 54 °C for 15 s, and 72 °C
for 30 s, with a final extension step of 7 mins at 72 °C.
The gene fragment was designed to produce an EcoRI
restriction endonuclease site at the 5’ end and a HindIII
site at the 3’ end. The resultant PCR products were
subcloned into the overexpression plasmid pET28a, thus
generating pET28a-stx2eB. The E. coli BL21 (DE3) pLysS
strain was transformed with pET28a-stx2eB. Stx2eB pro-
tein was purified as described previously [19]. The stx2eB
gene-containing DNA fragments derived from pET28a-
stx2eB were subcloned into EcoRI/HindIII-digested
pJHL184 to generate the recombinant plasmid pJHL184-
stx2eB [17]. Stx2eB secretion into the periplasmic space
is achieved by fusion with the signal sequence of E. coli
outer membrane protein OmpA, which was subcloned
into the MCS of pJHL184. pJHL184-stx2eB was initially
transformed into E. coli χ6212 (JOL232) to maintain the
stability of the plasmid in the absence of antibiotics, and
the plasmid subsequently was introduced into JOL912
by electroporation. The resultant strain was designated
as JOL1454. The Δasd Δlon ΔcpxR S. Typhimurium
strain JOL1400, carrying pJHL184, was used as a vector
control.
Production of Salmonella ghosts bearing Stx2eB
A single colony of JOL1454 was inoculated into nutrient
broth containing 0.2% L-arabinose, and the inoculum
was incubated at 28 °C with agitation at 120 rpm until
mid-logarithmic growth phase to achieve mass produc-
tion of the strain. The cells were collected and washed
twice with nutrient broth (NB) to remove L-
arabinose. The cells were resuspended in 100 ml NB
and incubated at 42 °C in a shaking incubator at
200 rpm to induce E gene-mediated lysis over the
course of 48 h. After lysis, the ghost cells were har-
vested via centrifugation at 13,000 rpm for 15 min,
washed twice with sterile phosphate-buffered saline
(PBS) (pH 7.4), and stored at −70 °C.
Stx2eB expression in JOL1454
Western blot analysis was performed to verify the ex-
pression of Stx2eB antigen from JOL1454, as previously
described [19]. Bacterial ghosts expressing the target
antigen, and hyperimmune rabbit serum raised against
Stx2eB, were prepared as previously described [19]. Pro-
tein lysates of the prepared ghost cells (5 μl) were sub-
jected to sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) on 15% gels. Resolved pro-
teins were transferred onto polyvinylidene fluoride
membranes (Millipore, Billerica, MA, USA), immuno-
blot analysis was performed, and immunoreactive bands
were detected as previously described using hyper-
immune rabbit serum raised against Stx2eB (1:5,000)
and a HRP-labeled goat anti-rabbit IgG (1:8,000) [19].
JOL1400, JOL912 carrying pJHL184 and the purified
Stx2eB protein were utilized as negative and positive
controls, respectively. Subsequently, the amount of
Stx2eB expressed in JOL1454 was relatively quantified in
a calibration standard using indirect enzyme-linked
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immunosorbent assays (ELISA) [21]. Stx2eB containing
6 × His-tag at the C-terminal end in JOL1454 were puri-
fied by Ni–NTA spin columns (Ni–NTA Spin Kit,
Qiagen) according to the manufacturer’s instruction.
The His-tagged Stx2eB protein in a volume of 5 ml of
the prepared ghost cell (1 × 108 cfu per ml) were eluted
from the column with 2 ml of elution buffer (7 M urea:
7 M urea; 0.1 M sodium dihydrogen phosphate; 0.01 M
Tris · Cl; pH 8.0). A calibration standard was generated
by using twofold serial dilutions of Stx2eB protein ex-
tracted from BL21 harboring pET28a-stx2eB. The diluted
protein samples ranging from 1 μg to 31.25 ng, and the
purified His-tagged protein as antigen were coated in
the ELISA plate (Greiner) and incubated at 4 °C over-
night. After the incubation, the hyperimmune rabbit
serum raised against Stx2eB (1:300) and a HRP-labeled
goat anti-rabbit IgG (1:5,000) were used as primary and
secondary antibodies, respectively as previously de-
scribed [19]. The concentration of the His-tagged Stx2eB
protein expressed in JOL1454 were calculated by the
known concentration of the purified Stx2eB correspond-
ing to values of optical density at 490 nm in the calibra-
tion standard. The final concentration of the protein
presented was based on the number of cells in initial
bacterial culture.
Animal experiments
Eighteen female BALB/c mice were randomly assigned
to two groups at five weeks of age. The mice in group A
were intramuscularly immunized with 1 × 108 JOL1454
ghost cells at weeks zero and two. PBS was injected into
the mice in group B, which served as a non-immunized
control group. For measurement of total serum im-
munoglobulin (Ig) G, as well as of IgG1 and IgG2a,
serum samples were collected, and for measurement of
secretory IgA (sIgA), vaginal wash samples were col-
lected, as previously described [20], at weeks 0, 2, 4 and
6. All samples were stored at −70 °C until used. For
immunological assays using the primed splenocytes,
additional 10 mice (5 mice per group) were inocu-
lated at week 0 using the same protocol described
above. Further, although ED results from oral trans-
mission of the pathogen in natural infections, we
found that ED did not occur in BALB/C model mice
orally challenged with JOL654. However, intraperito-
neal injection with the challenge strain efficiently in-
duced symptoms in mice similar to those of ED such
as hemorrhage in small intestine and bloody diarrhea.
At week 7, non-immunized and immunized mice were
intraperitoneally challenged with wild type STEC
JOL654 isolated from porcine diarrhea (Table 1). The
murine sublethal dose (2 × 107 CFU) was determined
by the Reed-Muench method [22] following a proto-
col used in a previous study [10]. Mice were
monitored daily for mortality, clinical signs, and body
weight for one week after inoculation.
Humoral and cellular immunological response
Stx2eB-specific titers of total IgG, the IgG1 and
IgG2a isotypes, and secretory IgA (IgA) in sera or va-
ginal washes, as appropriate, were measured by ELISA
[19] on 96-well plates with 500 ng of purified Stx2eB
protein coating each well. Fluorescence-activated cell
sorting (FACS) was used to assay changes in T cell
subpopulations induced by immunization. Splenocytes
were aseptically isolated from mice at day seven post-
immunization, and single-cell suspensions were pre-
pared. One million cells were stained by combining
them with anti-mouse CD3a-PE and anti-mouse CD4-
perCP-vio700 antibodies (Miltenyi Biotec, Bergisch
Gladbach, Germany) and incubating for 20 min. After
washing twice with FACS buffer (Miltenyi Biotec, Ber-
gisch Gladbach, Germany), changes in CD3+ and CD4
+ T cell subpopulations were determined using a
MACSQuant® analyzer (Miltenyi Biotec, Bergisch
Gladbach, Germany). Splenocyte proliferation follow-
ing antigen stimulation in vitro was assessed by in-
corporation of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide), which is only converted
to blue formazan dye by actively proliferating cells
[23]. Splenocytes were isolated from the immunized
group at week two post-immunization (PI). Suspen-
sions of 1 × 106 single cells were cultured in tripli-
cate with 500 ng/ml of stx2eB antigen in RPMI 1640
medium (GIBCO, cat. no.11875093) containing 5%
FCS (GIBCO, cat. no. 10099141), at 37 °C in a 5%
CO2 incubator for 72 h. Following stimulation, the
cells were incubated with MTT (1 mg/ml) for another 4 h.
The precipitated blue formazan in each well was solubi-
lized in dimethyl sulfoxide, and colorimetric absorbance
was measured as optical density (OD) at 570 nm with a
spectrophotometer. The results are presented as a stimu-
lation index, calculated as the mean OD value of the wells
stimulated with antigen, divided by the mean OD value of
the unstimulated wells.
Cytokine measurement
Induction of expression at the mRNA level of the cyto-
kines, interleukin-4 (IL-4) and interferon-γ (IFN-γ), in-
duced by immunization of the mice was measured by
reverse transcription real-time PCR. At week 2 PI, sple-
nocytes were isolated from immunized and non-
immunized mice. Viable cells (1 × 106) stimulated with
500 ng/ml of Stx2eB protein were incubated in a 96-well
cell culture plate with RPMI 1640 medium supple-
mented with 20% fetal bovine serum (FBS) in a humidi-
fied 5% CO2 atmosphere for 72 h. Total RNA from the
cultured cell suspensions was isolated using a GeneAll®
Won et al. BMC Veterinary Research  (2017) 13:40 Page 4 of 11
Hybrid-R™ kit (GeneAll Biotechnology, Seoul, Korea) and
converted into cDNA with a ReverTra Ace® qPCR RT
Kit (FSQ-101, TOYOBO, Japan). Levels of IL-4 and IFN-
γ mRNA expression were quantified by real-time reverse
transcription polymerase chain reaction (RT-PCR). The
sequences of the primer pairs used to amplify IL-4, IFN-
γ and β-actin (used as an internal standard) were those
described by Lut et al. [24]. The mRNA expression levels
of the cytokines were determined by the threshold
method, using Cycle threshold (ΔCT) values calculated
based on the internal standard. The fold change of the
mRNA levels compared to those of the non-immunized
group is expressed as 2-(ΔΔCT) [25].
Cytokine profiles assessed in porcine PBMC pulsed with
JOL1454
To determine the extent of porcine lymphocyte activa-
tion following stimulation of the lysed S. Typhimurium
expressing Stx2eB, immunomodulatory cytokines were
measured in mRNA level in naïve porcine peripheral
blood mononuclear cells (PBMC) pulsed in vitro with
JOL1454. Naïve porcine PBMCs were obtained from
2 ml of blood samples of five non-vaccinated pigs (15-
18 kg, 6 weeks of age) raised at an experimental animal
farm of the college by density gradient centrifugation
using Histopaque-1077® solution (Sigma, St. Louis, MO)
following the manufacturer’s instruction. After the
PBMC isolation, the cells were placed in RPMI 1640
medium supplemented with 1% fetal bovine serum and
1% glutamine/penicillin/streptomycin (Thermo Scien-
tific), and then plated at a density of 5 × 106 per well in
96 well cell culture plate. Subsequently, the resuspended
cells were treated with the lysed JOL1454 with 10 multi-
plicity of an infection (MOI), and were incubated for
48 h at 37 °C in a humidified atmosphere of 5% CO2.
Following the incubation, the pulsed cells were lysed
directly in 500ul of Trizol reagent for RNA extraction.
The preparation of RNA and cDNA were carried out as
described above and 2 μl synthesized cDNA were added
as qRT-PCR template. Cytokine (IL-6, IL-17A, IL-21,
IFN-γ) mRNA expressions were determined by using the
primer pairs [26–28] with SYBR® Green Realtime PCR
Master Mix (QPK-201, TOYOBO, Japan) following the
manufacturer’s instruction. Porcine glyceraldehyde-3-
phosphate dehydrogenase (GADPH) and 60s ribosomal
protein L19 (RPL-19) genes were used as reference genes
for normalization [29]. ΔCT values were standardized by
the average Ct values of two internal controls and non-
stimulated cells. Relative fold changes were determined
by 2-ΔΔCT method [25].
Statistical analysis
Data are presented as mean ± standard deviation (s.d.).
One-way ANOVA test was used to evaluate significant
differences in immune responses between the immu-
nized and non-immunized groups. Statistical differences
were considered significant when P values were <0.05.
Results
Construction of Salmonella ghosts expressing Stx2eB
The Stx2eB gene was cloned under control of a constitu-
tive promoter in the pJHL184 plasmid, which contains a
convergent promoter system tightly regulating the in-
duction of the E lysis gene and consequent lysis of
JOL1454. To constitutively express stx2eB, JOL1454 cells
were grown at 42 °C for 48 h in the absence of L-
arabinose. Lysis of JOL1454 was confirmed by the
inviability of cells plated from JOL1454 cultures grown
at 42 °C. No viable cells were observed on LB plates after
overnight incubation under conditions wherein the E
gene was repressed (data not shown). The Stx2eB pro-
tein fused to ompA expressed in JOL1454 was verified
by western blot analysis. The distinct immuno-reactive
band of Stx2eB fused with OmpA was observed at
~24 kDa (Fig. 1; lane 1). Considering that the size of
Stx2eB protein is ~13 kDa, we speculated that OmpA ss
were properly fused with the target protein. In the lane 1
of Fig. 1 in which the lysed JOL1400 was loaded, the
band corresponding to the size of Stx2eB was not
shown. For the positive control, Stx2eB fused to 6xHis
purified from pET28a-stx2eB in BL21 was loaded where
immuno-reactive band was detected (Fig. 1; lane 3). The
relative amount of Stx2eB protein expressed in JOL1454
was estimated by the linear regression standard curve
showing a fit of R2 = 0.971. Concentration of the His-
Fig. 1 Western blot analysis of Stx2eB protein expressed in JOL1454
cells. The Stx2eB protein expressed and secreted by JOL1454 cells
was detected by western blotting with rabbit anti-Stx2eB antibody.
The arrow indicates the expected size of the fusion protein. JOL1400,
consisting of JOL912 cells containing the empty vector pJHL184 and
purified Stx2eB were used as a negative and positive control, respectively.
Lane M, size marker; lane 1: vector control; lane 2: JOL1454; lane 3:
purified Stx2eB
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tagged Stx2eB was approximately 909.18 ng per 108 cfu
of JOL1454.
Humoral and mucosal immune responses raised by
immunization
The immunogenicity induced by JOL1454 immunization
of the mice was assessed by measuring Stx2eB-specific
serum IgG and sIgA titers. The sIgA and IgG titers
specific to the Stx2eB antigen were significantly elevated
(P <0.05) in the JOL1454 group compared to those in
the control group (Fig. 2). The IgG titers significantly in-
creased at week 4 (P <0.05, 2.59-fold) and week 6 post-
immunization (PI) (P <0.001, 2.79-fold) compared to
those measured in the negative control. The concentra-
tion of sIgA was moderately increased at week 2 PI and
was significantly raised in comparison to those in the
negative control at week 4 and 6 PI (P <0.05). Further-
more, the ratio of the IgG1 to IgG2a (IgG1/IgG2a) im-
munoglobulin isotypes, markers of T helper 2 (Th2) and
T helper1 (Th1) lymphocytes, respectively, was calcu-
lated from the titers of the individual isotypes. JOL1454
immunization induced IgG1 to a greater degree than it
did IgG2a (Fig. 3). The level of IgG1 was consistently
higher than that of IgG2a throughout the entire observa-
tion period (Fig. 3).
T lymphocyte proliferation induced by immunization
Changes in splenic T cell fractions at week one post-
immunization were assessed by measuring expression
of the T cell surface markers CD3 and CD4 using
flow cytometry. Both the CD3+ T cell population and
CD3+CD4+ T cell subpopulations were significantly el-
evated (P <0.05, respectively) in JOL1454-immunized
mice (Fig. 4a), leading to significant average increases
of 3.52% and 2.6% in the CD3+ and CD3+CD4+ T cell
subpopulations, respectively, compared to the non-
immunized group. In the MTT cell viability assay, the
JOL1454-immunized mice showed a significant in-
crease (P <0.05) in stimulation index (SI) at week 2
PI, resulting in a significantly increased mean SI of
2.54 ± 0.49 in the immunized group, compared to
1.26 ± 0.29 in the PBS control group (Fig. 4b).
Cytokine measurement
To evaluate immunomodulatory cytokines secreted
by the stimulated splenic lymphocytes, mRNA copy
numbers of the IL-4 and IFN-γ cytokines were ana-
lyzed by qPCR. Fold changes were normalized
against the murine β-actin gene. In vitro stimulation
of splenic T cells with JOL1454 resulted in marked
changes in relative fold values for the IFN-γ (P
<0.05) and IL-4 (P = 0.01) cytokines in the immu-
nized group compared to those in the control group
(Fig. 5). These results indicated that the expression
of IL-4 and IFN-γ in the immunized group were sig-
nificantly upregulated compared to the control
group, following stimulation of splenic T cells with
Stx2eB.
Fig. 2 Stx2eB antigen-specific humoral immune responses in
immunized and non-immunized mice. Titers of a serum IgG, and
b secretory IgA in ng/ml. Data are presented as the means of all
mice in each group (n = 9), and error bars indicate s.d. *, P < 0.05
and **, P < 0.001 vs. control group at each week post-immunization
Fig. 3 The levels of two IgG isotypes, IgG1 and IgG2a, elicited by
JOL1454 immunization. The values indicate the means of optical
density at 450 nm from sera collected from immunized mice (n = 9),
and error bars indicate standard deviation (s.d). The numbers above
the bars indicate the IgG1/IgG2a ratios. PI: post-immunization
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Immunomodulatory cytokines measured in the activated
porcine PBMC
In vitro stimulation of porcine PBMCs with JOL1454 in-
duced upregulation of immunomodulatory cytokine gene
expressions (Fig. 6). The expression of IFN-γ, one of
Th1-specific cytokine [29] and IL-6 promoting Th2
responses [30] increased up to 28.9 ± 8.5 and 15.13 ±
3.7 fold, respectively. Gene expression of IL-17A in-
volving with differentiation of Th17 cells [31], were
predominantly upregulated in the stimulated PBMC
(71.88 ± 12.29-fold). Concomitantly, a moderate in-
crease of expression of IL-21 produced by Th17 cells
[32, 33] (6.07 ± 1.73-fold) were also observed in the
pulsed PBMCs.
Protective efficacy conferred by JOL1454
To assess the protective efficacy conferred by JOL1454
immunization, all immunized mice were intraperitone-
ally injected with a sublethal dose of virulent STEC
JOL654 at week 7 PI. The survival rates and weight
losses of the mice were monitored in immunized and
non-immunized animals for seven days after challenge.
In both the immunized and the control group mice,
weight loss, which began only following the challenge,
was observed through day 1 post-challenge. While the
weights of the immunized animals rapidly recovered,
body weight of the negative control was markedly
dropped compared to the immunized mice at days 2, 3,
4 and 7 post challenge (P <0.05) (Fig. 7b). All immunized
mice survived during the entire observation period, but
22.2% of the non-immunized mice died within 18 h of
Fig. 4 T cell-related immune responses elicited in JOL1454-immunized mice. Representative flow cytometry scatter dot plots for CD3+ and CD3 + CD4+
splenic T cell populations of non-immunized mice (a) and the immunized mice (b). The subpopulations are presented as a percentage of gated cells.
CD3+ and CD3 + CD4+ T lymphocyte populations in immunized and non-immunized mice (c) and stimulation index (SI) values of splenic T cells of the
purified Stx2eB protein-immunized group, determined by MTT assay (d). The values are expressed as the mean ± s.d. of five individual values. *, P< 0.05
Fig. 5 Cytokine mRNA transcript levels in stimulated and unstimulated
splenic T cells isolated from JOL1454-immunized mice. The mRNA
transcript levels of cytokines were evaluated by performing RT q-PCR
with gene-specific primers. Each fold change value represents the
mean ± standard error of the mean (SEM) of five individual values.
*P < 0.05 when values were compared with the control group
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challenge (Fig. 7a). Clinical signs such as diarrhea,
hunched posture, and hair election were also observed
in non-immunized mice.
Discussion
Stx2eB is not only an intrinsically non-toxic and im-
munogenic protein of STEC but also a proven candidate
vaccine antigen for prevention and control of ED in pigs
[34]. In this study, we constructed an autolyzed S.
Typhimurium strain expressing Stx2eB, which we desig-
nate as JOL1454, and confirmed the expression of
Stx2eB fused with the six transmembrane domains
(TMD) of the E. coli outer membrane protein A (OmpA)
in this strain (Fig. 1). OmpA signal peptides have been
successfully employed to translocate target antigens
across the cytoplasmic space or insert proteins into the
outer membranes of gram-negative bacteria [35]. In the
present study, detection of Stx2eB protein expression in
the cell pellet indicated that the OmpA signal peptide ef-
ficiently directed the expressed Stx2eB in the Salmonella
ghosts (Fig. 1). Additionally, the relative amount of the
His-tagged Stx2eB protein was measured in the lysed
JOL1454. The significantly elevated levels of antibodies
specific to Stx2eB in mice immunized with JOL1454
(Fig. 2) demonstrated that modified S. Typhimurium
mediated efficient expression of Stx2eB on the outer
membrane of the Salmonella ghosts.
In this study, immunization of mice with JOL1454
markedly elevated their titers of anti-Stx2eB IgG and
sIgA (Fig. 2). The in vivo role of systemic IgG (sIgG) in
neutralizing Shiga toxin has been emphasized in strat-
egies to protect piglets against ED [36]. Stx-specific sIgG
antibodies can protect immunized pigs against systemic
infection with STEC, and the magnitude of protection
relies on the dose of the antibodies [37]. sIgA antibodies,
however, serve as the first line of defense against infec-
tion at mucosal surfaces [38]. As the natural infection of
STEC occurs via the oral route, sIgA also has an essen-
tial role in preventing adherence or attachment of path-
ogens [39]. These findings indicate that immunization
with JOL1454 may mediate protection against ED by eli-
citing humoral and mucosal immune responses against
Stx2eB.
The IgG isotypes, IgG1 and IgG2a, are regarded as
markers of T helper (Th) 2- and Th1-type immune re-
sponses, respectively [40]. The Fc portions of the IgG1
and IgG2a antibodies primarily interact with the activa-
tory Fc-γ receptors (FcγR) III and FcγR IV, which elicit
Th2- and Th1-type immune responses, respectively [41].
The IgG1-to-IgG2a (IgG1/IgG2a) ratio has been used to
determine the relative contribution of Th2- versus Th1-
type immune responses to STEC infection [42]. In our
current study, the IgG1/IgG2a ratio declined from 2.79
to 1.66 in response to JOL1454 immunization (Fig. 3).
Fig. 6 The mRNA expression of cytokines evaluated in in vitro
stimulated porcine PBMC. The immunomodulatory cytokines were
measured in mRNA level by using qRT PCR. Relative fold changes
were calculated based on 2-ΔΔCT method. Data are presented with
the mean ± SEM (n = 5)
Fig. 7 Protective efficacy against challenge with a sublethal dose of
JOL654 conferred by JOL1454. a Survival rates of immunized and
non-immunized mice after challenge. b Percentage (%) in mouse
body weight. Each point represents the mean of 9 mice per group,
and error bars indicate s.d. *P < 0.05 or **P < 0.01 when values were
compared with the control group
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The decreased ratio indicated that the contribution of
IgG2a antibodies continuously increased during the
observation period (Fig. 3). This implies that, despite the
predominance of the Th2 subpopulation, the Th1
immune response was steadily elevated in JOL1454-
immunized animals.
Naïve CD4 + T lymphocytes stimulated with an anti-
genic peptide differentiate into Th1 and Th2 subpopula-
tions [43]. Th1 and Th2 cells promote cell-mediated
immune responses involving antigen-specific cytotoxic
effects and humoral immune responses, respectively
[44]. JOL1454 immunization significantly elevated the
CD3+CD4+ T cell subpopulations in mice, (Fig. 4a), indi-
cating that JOL1454 can stimulate naïve CD4+ T cell
maturation. Additionally, we observed that the copy
numbers of IL-4 and IFN-γ mRNA were significantly
elevated in restimulated splenic lymphocytes of the
immunized mice (Fig. 5). The immunomodulatory cyto-
kines, IFN-γ and IL-4, are exclusively expressed in
mature Th1 and Th2 cells, respectively [43]. Thus, this
observation supports the interpretation that JOL1454
was able to efficiently stimulate CD4+ T cell differenti-
ation into Th1 and Th2 subpopulations, which drive the
induction of cellular and humoral immune responses,
respectively.
Salmonella ghosts elicit robust cell-mediated immune
responses (CMI), as they retain the entire surface anti-
genic determinants of their pre-lysed condition, in the
native forms thereof [10]. We observed markedly en-
hanced in vitro SI in re-stimulated splenic T cells of
JOL1454-immunized mice (Fig. 4B). This implies that
JOL1454 can induce lymphocyte proliferation, which is a
primary parameter of CMI responses. In parallel, mRNA
levels of IFN-γ, a marker of CMI, were significantly ele-
vated in splenic T cells after in vitro restimulation. In a
previous report, mice immunized with purified Stx2eB
protein did not show increased serum levels of IFN-γ
[36]. These results support the conclusion that the Sal-
monella ghost system delivering Stx2eB can induce CMI
responses in immunized mice.
Ren et al. constructed a plasmid expressing Stx2eB for
use as a candidate vaccine, and investigated its protect-
ive efficacy using the construct in a mouse model [45].
In that study, immunized mice were intraperitoneally
challenged with a virulent ED-associated E. coli, and
80% of the immunized mice survived. Immunization of
mice with JOL1454 in our study also offered highly
effective protection against a challenge with wild-type
STEC. While no mortality occurred in any of the immu-
nized mice, approximately 30% of the mice in the non-
immunized group died. The protection conferred by
JOL1454 immunization might be due to the following:
JOL1454 Salmonella ghosts efficiently secreted Stx2eB
in the cells due to fusion of the protein with ompA ss;
Stx2eB delivered by JOL1454 ghosts elicited circulating
antibodies specific to Stx2eB, which may neutralize
Shiga toxin; and Salmonella ghosts bearing Stx2eB can
trigger CMI responses mediating phagocytosis and
elimination of the challenge strain. Additionally,
JOL1454 efficiently induced upregulated expression of
immunomodulatory cytokines involved with activation
of Th1, Th2 and Th17 cells in the pulsed porcine PBMC
(Fig. 6), which implicated that JOL1454 may have a cap-
acity to differentiate naïve porcine lymphocytes toward
matured CD4+ T cell subpopulation. Particularly, the in-
creased expression of IL-6, IL-17A and IL-21 in the
present study indicated Th17 cells was matured and
activated in the pulsed porcine lymphocytes, which is
crucial for intestinal mucosal host defense [46]. These
preliminary data supported that JOL1454 has a potential
to elicit subsequent immune responses following the
cytokine production in porcine.
Conclusions
The present data indicate that Stx2eB delivered by a
Salmonella ghost strain could effectively stimulate the
immune system so as to confer sufficient protection to
prevent ED. The results also suggest that Salmonella
inactivated by E gene-mediated lysis that preserves their
intact antigenic determinants may not only effectively
deliver the target antigen but also provide an adjuvant
property. Additionally, given the immunostimulatory
effect of JOL1454 which can elicit immunomodulatory
and proinflammatory cytokines in the porcine lympho-
cyte, this autolyzed Salmonella strain producing Stx2eB
may constitute a novel alternative approach to develop-
ing an effective vaccine candidate against porcine edema
disease.
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